Jolley Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-224
| Closed | -$10K | – | 185 |
|
|
2017
Q4 | $10K | Sell |
224
-74,130
| -100% | -$3.31M | 0.01% | 147 |
|
|
2017
Q3 | $3.77M | Buy |
74,354
+8,225
| +12% | +$417K | 2.56% | 22 |
|
|
2017
Q2 | $3.56M | Buy |
66,129
+1,795
| +3% | +$96.7K | 2.5% | 24 |
|
|
2017
Q1 | $3.39M | Buy |
64,334
+2,103
| +3% | +$111K | 2.44% | 26 |
|
|
2016
Q4 | $3M | Buy |
62,231
+4,905
| +9% | +$236K | 2.15% | 28 |
|
|
2016
Q3 | $3.09M | Sell |
57,326
-7,655
| -12% | -$413K | 2.5% | 26 |
|
|
2016
Q2 | $3.52M | Buy |
64,981
+470
| +0.7% | +$25.5K | 2.83% | 15 |
|
|
2016
Q1 | $3.27M | Buy |
64,511
+5,810
| +10% | +$295K | 2.98% | 13 |
|
|
2015
Q4 | $2.96M | Sell |
58,701
-206
| -0.3% | -$10.4K | 2.82% | 18 |
|
|
2015
Q3 | $2.83M | Sell |
58,907
-79
| -0.1% | -$3.8K | 2.87% | 18 |
|
|
2015
Q2 | $3.07M | Sell |
58,986
-602
| -1% | -$31.3K | 2.79% | 21 |
|
|
2015
Q1 | $3.44M | Buy |
59,588
+6,445
| +12% | +$372K | 2.85% | 19 |
|
|
2014
Q4 | $2.84M | Sell |
53,143
-582
| -1% | -$31.1K | 2.35% | 27 |
|
|
2014
Q3 | $3.09M | Buy |
53,725
+8,952
| +20% | +$514K | 2.49% | 28 |
|
|
2014
Q2 | $2.99M | Sell |
44,773
-785
| -2% | -$52.5K | 2.2% | 30 |
|
|
2014
Q1 | $3.04M | Buy |
45,558
+903
| +2% | +$60.3K | 2.26% | 28 |
|
|
2013
Q4 | $2.98M | Buy |
44,655
+469
| +1% | +$31.3K | 2.35% | 27 |
|
|
2013
Q3 | $2.77M | Sell |
44,186
-36
| -0.1% | -$2.26K | 2.31% | 27 |
|
|
2013
Q2 | $2.76M | Buy |
+44,222
| New | +$2.76M | 2.24% | 29 |
|